Björnsson E, Schröder R, Kowalski A. "Method for the Synthesis of Doxapram Impurity 34" [P]. European Patent, EP 3672882 A1, 2023-07-27.
发明人陈志强,朱建伟,赵玉洁. "A Process for Preparing High-Purity Doxapram Impurity 34" [P]. 中国发明专利, 专利号 CN 111570614 B, 授权公告日 2016-09-23.
参考文献 Literature
Garcia M, Rodriguez P. "Development and Validation of an LC-MS/MS Method for the Determination of 多沙普仑杂质34 in Pharmaceutical Formulations". J. Nat. Prod., 2016, 1498, 734-760.
Smith J A, Johnson M B. "A Stability-Indicating HPLC Method for the Separation and Quantification of 多沙普仑杂质34 as an Impurity". Anal. Chim. Acta, 2019, 983, 3830-3841.
Fischer P, Wagner E. "Identification and Structural Characterization of a Novel Degradation Product of Doxapram Impurity 34 Using HRMS and NMR". Environ. Sci. Technol., 2018, 2343, (10), 6113-6119.
O'Brien K, Kennedy M L. "Forced Degradation Studies to Evaluate 多沙普仑杂质34 Profile in Drug Substances According to ICH Guidelines". Food Chem., 2019, 639, (10), 5971-5994.